A small fragment of a llama antibody, also called ‘nanobody’, is capable of reducing human cytomegalovirus (HCMV) in patients, scientists at the Vrije Universiteit and University of Cambridge found in a study. This could lower CMV-associated diseases and mortality during life-saving solid organ and stem cell transplantation and could be a potential lifesaving drug.
HCMV infections are common. Almost half of the adults in the Netherlands have had HCMV infections. Healthy people with a HCMV infection usually do not experience symptoms. However, every year 170 babies in the Netherlands with HCMV do experience serious consequences, such as hearing loss. For people with a weakened immune system, such as transplant recipients who need to take immunosuppressant drugs to prevent organ rejection, reactivation of HCMV can also be harmful and even life-threatening. Currently, there is no effective vaccine against HCMV and drugs are often ineffective or have serious side effects.
As HCMV hides in blood cells, the scientists searched for an approach to chase away the virus. The Llama nanobody “reactivates the virus just enough to make it visible to the immune system, but not enough for it to do what the virus normally does, replicating and spreading,” explains Dr. Elizabeth Elder from University of Cambridge. As a consequence, the immune cells can find and kill the virus. Dr. Timo De Groof from Vrije Universiteit Amsterdam: “As the name suggests, nanobodies are much smaller than regular antibodies, which make them perfectly suited for particular types of antigens and relatively easy to manufacture and adjust. That’s why they’re being hailed as having the potential to revolutionise antibody therapies.”
Professor Martine Smit of VU concludes “we believe our approach could lead to a much-needed new type of treatment for reducing – and potentially even preventing – CMV infectious in patients eligible for organ and stem cell transplants.”
The project ChloroSpec, initiated by Alfred Holzwarth and Roberta Croce, establishes as BV. Lead by Peter Kievit (serial entrepreneur), ChloroSpec is a developer of plant health and stress analysis systems. ChloroSpec has developed a new technology that should become the gold standard in chlorophyll fluorescence monitoring of plants and algae, and analyzes how plants respond […]News
Mazi Jalaal – assistant professor at the Institute of Physics at the University of Amsterdam – has received a Physics2Market subsidy to work out his idea on a new technique to measure the mechanical properties of soft materials, based on image processing and artificial intelligence. The goal is to develop a cheaper and simpler rheometer, […]News
Dr. Ronald van Steden enters into a partnership with the Dutch police. Together they are committed to guide and monitor the new position of ‘director care and safety’ (regisseur zorg en veiligheid) in Amsterdam. Dr. Ronald van Steden, Associate Professor of Public Administration at the Vrije Universiteit Amsterdam and Senior Researcher at the NSCR, has […]News